MO
MOH.O
—
NASDAQ
Healthcare Services & Equipment
Molina Healthcare Inc
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
9,9B USD
P/E
—
EV / Rev
—
Div yield
—
Op margin
1,7 %
ROE
11,6 %
Net margin
1,0 %
Debt / equity
0,93
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$224,82
Open
$223,61
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
Molina Healthcare Inc operates as a health care provider and services company, generating revenue through managed care and health insurance services.
Business. Molina Healthcare Inc (MOH.O) is a health care provider and services company headquartered in the United States. The firm operates within the Health Care industry, focusing on health care providers and services. It is primarily listed on the NASDAQ stock exchange. Specific details regarding operating segments or geographic revenue mix are not provided.
Classification99 %
SectorHealth Care
Industry groupHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
HOLD21 analysts
4 buy16 hold1 sell
Avg 12m price target209,67
Analyst recommendations
21 analysts · consensus HoldBuy4
Hold16
Sell1
12-month price target
209,67
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Hold
21 analysts · indicative
Ownership→
iShares Core S&P Small-Cap ETF
largest disclosed fund holder
Profitability→
11,6 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,7 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,4 %−2,7 %−0,9 %
Real Estate−0,7 %+10,9 %−1,3 %
Consumer Staples−0,7 %+2,3 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to MOH.O. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressByron Donalds — Molina Healthcare Inc Common2025-09-04 · Republican · FL · Sale · $1,001 - $15,000
- CongressRob Bresnahan — Molina Healthcare Inc Common Stock2025-01-13 · Republican · PA · Sale · $1,001 - $15,000
- CongressEarl Blumenauer — Molina Healthcare Inc2023-06-15 · OR · Purchase · $15,001 - $50,000
Pre-earnings brief
Briefing · model-assisted
Molina Healthcare Inc (MOH.O) has entered the analysis scope for the first time, establishing a baseline for future monitoring. As this is the initial assessment for the ticker, there is no prior data to compute material changes or deltas in financial performance or operational metrics. The most significant activity detected involves a major modification in holder positions. Specifically, investor ID 587 adjusted their stake in the company, with records showing a shift in share count between 278.0 and 5,766.0 shares as of March 31, 2026. These changes were detected on June 27 and June 28, 2026, indicating active trading or reporting updates by this specific entity. Despite these holder adjustments, the broader ownership structure remains stable with 35 top holders identified. The company currently has no reported analyst coverage, officer count data, or index membership information available in the current dataset. This initial snapshot highlights the importance of tracking specific investor movements, such as those by ID 587, even in the absence of broader market signals. With no cross-source signals or sagas reported, the focus remains on establishing accurate baseline data for Molina Healthcare’s ownership and financial profile.
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Molina Healthcare Inc (MOH.O) is a health care provider and services company headquartered in the United States. The firm operates within the Health Care industry, focusing on health care providers and services. It is primarily listed on the NASDAQ stock exchange. Specific details regarding operating segments or geographic revenue mix are not provided.
Classification99 %
SectorHealth Care
Industry groupHealthcare Services & Equipment
AI synthesis
GENERATEDMolina Healthcare Inc (MOH.O) has entered the analysis scope for the first time, establishing a baseline for future monitoring. As this is the initial assessment for the ticker, there is no prior data to compute material changes or deltas in financial performance or operational metrics. The most significant activity detected involves a major modification in holder positions. Specifically, investor ID 587 adjusted their stake in the company, with records showing a shift in share count between 278.0 and 5,766.0 shares as of March 31, 2026. These changes were detected on June 27 and June 28, 2026, indicating active trading or reporting updates by this specific entity. Despite these holder adjustments, the broader ownership structure remains stable with 35 top holders identified. The company currently has no reported analyst coverage, officer count data, or index membership information available in the current dataset. This initial snapshot highlights the importance of tracking specific investor movements, such as those by ID 587, even in the absence of broader market signals. With no cross-source signals or sagas reported, the focus remains on establishing accurate baseline data for Molina Healthcare’s ownership and financial profile.
Key takeaways
- Molina Healthcare holds a net cash position with $4.25 billion in cash against $3.77 billion in long-term debt, supporting a low liquidity risk profile.
- Operating cash flow turned negative at -$535 million, a key metric to monitor for potential working capital or claim payment timing issues.
- The company trades at a P/E of 24.37 and EV/EBITDA of 14.11, reflecting a premium valuation relative to current earnings.
- Analyst sentiment is neutral with a mean recommendation of 2.76 and price targets below the current market price, suggesting limited near-term upside.
- No dilution risk is present, and the debt-to-equity ratio of 0.93 indicates manageable leverage.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$194,77
Market cap
$11.50B
Enterprise valueⓘ
$11.02B
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
2.8x
P / Tangible bookⓘ
2.8x
Tangible book
$4.07B
Net cashⓘ
$482.0M
Current ratioⓘ
—
Debt / equityⓘ
0.9
ROAⓘ
3.0%
ROEⓘ
11.6%
Cash conversionⓘ
-113.0%
CapEx / revenueⓘ
0.2%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships49 disclosed relationships · 2 types · extracted from filings & disclosures
Vendors1
CVS HEALTH CorpCVS.NVendor95%Source ↗
Subsidiaries48
EX21:0062299e24f9EX21:0062299e24f9Subsidiarie97%
EX21:0412be4503dcEX21:0412be4503dcSubsidiarie97%
EX21:0472ead3e53eEX21:0472ead3e53eSubsidiarie97%
EX21:0a726b1f4981EX21:0a726b1f4981Subsidiarie97%
EX21:0b28622ae896EX21:0b28622ae896Subsidiarie97%
EX21:0c75eae517c4EX21:0c75eae517c4Subsidiarie97%
EX21:0d9f1d61cdcaEX21:0d9f1d61cdcaSubsidiarie97%
EX21:105d5073768fEX21:105d5073768fSubsidiarie97%
EX21:16cae04a170eEX21:16cae04a170eSubsidiarie97%
EX21:288965a1f2c8EX21:288965a1f2c8Subsidiarie97%
EX21:2e8e6d94c03dEX21:2e8e6d94c03dSubsidiarie97%
EX21:335e64226666EX21:335e64226666Subsidiarie97%
EX21:33a250bc88d5EX21:33a250bc88d5Subsidiarie97%
EX21:47d1790fa185EX21:47d1790fa185Subsidiarie97%
EX21:52fab1e22d25EX21:52fab1e22d25Subsidiarie97%
EX21:5a19b3ec3ae8EX21:5a19b3ec3ae8Subsidiarie97%
EX21:5b69046889cbEX21:5b69046889cbSubsidiarie97%
EX21:5bc98b063f60EX21:5bc98b063f60Subsidiarie97%
EX21:5e01ebb23ee6EX21:5e01ebb23ee6Subsidiarie97%
EX21:693a6345d1a8EX21:693a6345d1a8Subsidiarie97%
EX21:694387f7be1aEX21:694387f7be1aSubsidiarie97%
EX21:6b080a6a1b0aEX21:6b080a6a1b0aSubsidiarie97%
EX21:73ebf23bbb4cEX21:73ebf23bbb4cSubsidiarie97%
EX21:76fc841190a7EX21:76fc841190a7Subsidiarie97%
EX21:7cdf42596a4aEX21:7cdf42596a4aSubsidiarie97%
EX21:85dcb33a9506EX21:85dcb33a9506Subsidiarie97%
EX21:8bb239f3d2edEX21:8bb239f3d2edSubsidiarie97%
EX21:8e9c6a4364d4EX21:8e9c6a4364d4Subsidiarie97%
EX21:8ea606ed60e1EX21:8ea606ed60e1Subsidiarie97%
EX21:95404060d23aEX21:95404060d23aSubsidiarie97%
EX21:a6e3a89db52eEX21:a6e3a89db52eSubsidiarie97%
EX21:aa730efb5969EX21:aa730efb5969Subsidiarie97%
EX21:abac341692eeEX21:abac341692eeSubsidiarie97%
EX21:b9ca5f620234EX21:b9ca5f620234Subsidiarie97%
EX21:be28b820f325EX21:be28b820f325Subsidiarie97%
EX21:c40daedd3bcdEX21:c40daedd3bcdSubsidiarie97%
EX21:c978b5bb727dEX21:c978b5bb727dSubsidiarie97%
EX21:ca0cda8ea0e7EX21:ca0cda8ea0e7Subsidiarie97%
EX21:d339ea99dff9EX21:d339ea99dff9Subsidiarie97%
EX21:d5df9b2ce5beEX21:d5df9b2ce5beSubsidiarie97%
EX21:d7d51e772dd2EX21:d7d51e772dd2Subsidiarie97%
EX21:dd1a2e22939fEX21:dd1a2e22939fSubsidiarie97%
EX21:e2ab7edcc68cEX21:e2ab7edcc68cSubsidiarie97%
EX21:e55311b066a5EX21:e55311b066a5Subsidiarie97%
EX21:e5588bcec084EX21:e5588bcec084Subsidiarie97%
EX21:f106fda35600EX21:f106fda35600Subsidiarie97%
EX21:f487cdbb0648EX21:f487cdbb0648Subsidiarie97%
EX21:fe6533cbb833EX21:fe6533cbb833Subsidiarie97%
Supply chain
Vendors → MOH ↔ Partners → Customers · click any node to drill
1 mention in 10-K0 from corporate websites0 from news dispatches
Updated 2026-06-24Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Full fiscal year~1 year ahead
Full fiscal year · our forecast vs guidance vs consensus
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 5,15 |
| Revenue | —no estimate | —no estimate | 44,3B USD |
| Operating income | —no estimate | —no estimate | 534,1M USD |
Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
Corporate eventM&A horizon
M&A probabilityconf 3 %
Probability
3 %
Base rate
3 %
Band
—
180-day horizon · target 2027-01-23 · 1,0× base rate
No acquirer candidates identified by the signal model.
Probabilistic model output — not investment advice. · generated 2026-07-27
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution21 analysts
Strong buy2
Buy2
Hold16
Sell1
Strong sell0
12-month price target$209,67 · Median $210,00
Low $129,00High $286,00
Operating income · consensus534,1M USD
EPS surprise
+114,1 %
reported vs consensus · beat
Revenue surprise
+2,5 %
reported vs consensus · beat
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$129,00
Mean$209,67
Median$210,00
High$286,00
Spot$194,77
+7.6 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskLow
Filing-based flags
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Op Margin1,7 %Bottom quartile
Net Margin1,0 %Below median
ROE11,6 %Above median
Capex / Rev0,2 %Below median
D/E0,93Below median
Cash Conv-1,13Bottom quartile
Corporate actions / M&A
M&A probabilityconf —
Probability
3 %
Base rate
3 %
Band
Low
180-day horizon · target 2027-01-23 · 1,0× base rate
No acquirer candidates identified by the signal model.
Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
How metrics are computed
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Return On Equitynet_income / total_equity
- Enterprise Valuemarket_cap - net_cash
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Source documents
- MOLINA HEALTHCARE, INC. Market data — financials · 2026-07-18
- Molina Healthcare Inc Market data — analyst estimates · 2026-07-18
- Molina Healthcare Inc Market data — ESG · 2026-07-18
- Molina Healthcare Inc HA canonical relationships · 2026-07-18
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,18 %$276M
- Investment Managers · as of 2026-03-310,17 %$382M
- Investment Managers · as of 2026-03-310,06 %$426M
- Investment Managers · as of 2026-03-310,05 %$0M
- Investment Managers · as of 2026-03-310,04 %$186M
- Investment Managers · as of 2024-06-300,03 %$1 543M
- Investment Managers · as of 2026-03-310,03 %$151M
- Institutional Investor · as of 2026-03-310,02 %$427M
- Institutional Investor · as of 2022-09-300,02 %$0M
- Investment Managers · as of 2026-03-310,02 %$34M
- Investment Managers · as of 2025-12-310,02 %$1 056M
- Investment Managers · as of 2026-03-310,02 %$21M
- Investment Managers · as of 2026-03-310,02 %$0M
- Investment Managers · as of 2026-03-310,01 %$97M
- Investment Managers · as of 2024-12-310,01 %$43M
- Investment Managers · as of 2026-03-310,01 %$63M
- Investment Managers · as of 2026-03-310,01 %$72M
- Funds · as of 2026-03-310,01 %$68M
- Investment Managers · as of 2026-03-310,01 %$134M
- Institutional Investor · as of 2026-03-310,01 %$44M
- Investment Managers · as of 2026-03-310,01 %$231M
- Investment Managers · as of 2026-03-310,01 %$123M
- Investment Managers · as of 2026-03-310,01 %$51M
- Institutional Investor · as of 2026-03-310,00 %$20M
- Investment Managers · as of 2026-03-310,00 %$13M
- Investment Managers · as of 2026-03-310,00 %$6M
- Institutional Investor · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$3M
- Brokerage Firms · as of 2026-03-310,00 %$4M
- Brokerage Firms · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Insider activity
Net selling1 buys · 3 sellsnet -$3,4M15 insiders · last 365d
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- EVP, Medicaid · Common StockOther 183 @ $232,55$43K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Director · Common StockOther 237 @ $232,55$55K · 2026-07-01
- Chief Legal Officer · Common StockOther 138 @ $147,51$20K · 2026-06-30
- Chief Operating Officer · Common StockOther 144 @ $147,51$21K · 2026-06-30
- EVP, Medicaid · Common StockOther 23 @ $147,51$3K · 2026-06-30
- Chief Accounting Officer · Common StockSold 600 @ $191,55$115K · 2026-05-14
- Chief Legal Officer · Common StockSold 17 811 @ $186,12$3,3M · 2026-05-11
- Director · Common StockOther 170 @ $197,44$34K · 2026-05-06
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockOther 405 @ $135,82$55K · 2026-04-01
- Director · Common StockSold 506 @ $146,92$74K · 2026-03-12
Short positioning
3.3Mshares short+1.4% vs prior
3.49days to cover
64.5%short of daily vol
199fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Held by funds 1
- BlackRock (iShares) · ETF0,64 %80,0B $ · #36
Funds (by AUM rank) that hold this security, with each fund's portfolio weight in this name.
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
MOHCanonical
NASDAQ · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskLow
No immediate filing-based liquidity or dilution flags were detected.
Relationship graph
This companySectorVendorsSubsidiaries
Evidence & claims
From filings & derived data- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 3.2%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -9.5%Derived (calculated)
- Net margin (FY 2025-12-31): 1.0%Derived (calculated)
- Return on equity (FY 2025-12-31): 11.6%Derived (calculated)
- Return on assets (FY 2025-12-31): 3.0%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.69xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 2.83xDerived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): -0.4%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 1.0%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -8.9%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 14.7%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 11.7%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -56.5%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -56.3%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 28.8%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -183.1%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -54.2%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -60.0%Derived (calculated)
- Shares outstanding (annual): 51MSEC XBRL filing
- Cost of revenue (annual): USD 39.49BSEC XBRL filing
- Pre-tax income (annual): USD 589MSEC XBRL filing
- Revenue (annual): USD 45.43BSEC XBRL filing
- Total assets (annual): USD 15.56BSEC XBRL filing
- Net income (annual): USD 472MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-07-22 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
2026-07-22EVENTQ2 2026 earnings (expected) estimated date
2026-07-01 02:26 UTCNEWSSingapore to discontinue non-emergency ambulance hotline 1777 in 2027 → The Singapore Civil Defence Force will shut down its dedicated non-emergency ambulance line on Jan 1, 2027, as authorities consolidate emergency response channels.
2026-07-01INSIDERSOISTMAN FRANCIS S JR transacted 237 sh — Director ~$55k
2026-07-01INSIDERBRASIER BARBARA L transacted 237 sh — Director ~$55k
2026-07-01INSIDERROMNEY RONNA transacted 237 sh — Director ~$55k
2026-07-01INSIDERORLANDO STEVEN J transacted 237 sh — Director ~$55k
2026-07-01INSIDERWOLF DALE B transacted 237 sh — Director ~$55k
2026-07-01INSIDERBacon Debra transacted 183 sh — EVP, Medicaid ~$43k
2026-07-01INSIDERZORETIC RICHARD C transacted 237 sh — Director ~$55k
2026-07-01INSIDERSchapiro Richard M transacted 237 sh — Director ~$55k
2026-07-01INSIDERLockhart Stephen H transacted 237 sh — Director ~$55k
2026-07-01INSIDERGROHOWSKI LEO P transacted 237 sh — Director ~$55k
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
2026-06-30INSIDERBarlow Jeff D. transacted 138 sh — Chief Legal Officer ~$20k
2026-06-30INSIDERWOYS JAMES transacted 144 sh — Chief Operating Officer ~$21k
2026-06-30INSIDERBacon Debra transacted 23 sh — EVP, Medicaid ~$3k
2026-06-28 03:14 UTCHOLDERInstitutional holding changed
2026-06-28 03:14 UTCHOLDER1 institutional position change flagged (1 major)
2026-06-27 03:14 UTCHOLDERInstitutional holding changed
2026-06-27 03:14 UTCHOLDER1 institutional position change flagged (1 major)
2026-05-14 00:00 UTCINSIDER3 insider transactions — 2026-05 · net sell $3.4M
2026-05-14INSIDERHEBERT MAURICE sold 600 sh — Chief Accounting Officer ~$115k
2026-05-11INSIDERBarlow Jeff D. sold 17.8k sh — Chief Legal Officer ~$3.31M
2026-05-06INSIDERSOISTMAN FRANCIS S JR transacted 170 sh — Director ~$34k
2026-04-01 00:00 UTCINSIDER8 insider transactions — 2026-04 · net buy $440k
2026-04-01INSIDERROMNEY RONNA transacted 405 sh — Director ~$55k
2026-04-01INSIDERGROHOWSKI LEO P transacted 405 sh — Director ~$55k
2026-04-01INSIDERLockhart Stephen H transacted 405 sh — Director ~$55k
2026-04-01INSIDERORLANDO STEVEN J transacted 405 sh — Director ~$55k
2026-04-01INSIDERWOLF DALE B transacted 405 sh — Director ~$55k
2026-04-01INSIDERZORETIC RICHARD C transacted 405 sh — Director ~$55k
2026-04-01INSIDERSchapiro Richard M transacted 405 sh — Director ~$55k
Showing the 40 most recent of 55 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data
Premium coverage